For the period of 20 December 2021 to 31 December 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU) Document Link: 20 December – 31 December 2021
Preliminary Recommendation for the Inclusion of Sambong 250mg Tablets as Anti-Urolithiasis
Document link: MEDICINES RECOMMENDED FOR INCLUSION IN THE PHILIPPINE NATIONAL FORMULARY (PNF) (Proponents may submit appeals to hta@doh.gov.ph until 04 January 2022 using the prescribed appeal form.) Document Preview:
Evidence brief for 13 December to 17 December 2021
For the period of 13 December 2021 to 17 December 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU) Document Link: 13 December to 17 December 2021
Preliminary Recommendation on Emtricitabine + Tenofovir Disoproxil Fumarate fixed-dose combination as Oral Pre-Exposure Prophylaxis (PrEP)
Document link: MEDICINES RECOMMENDED FOR INCLUSION IN THE PHILIPPINE NATIONAL FORMULARY (PNF) (Proponents may submit appeals to hta@doh.gov.ph until 30 December 2021.) Document Preview:
Evidence brief for 04 December to 10 December 2021
For the period of 04 December to 10 December 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU) Document Link: 04 December to 10 December 2021